Empagliflozin preserves hemodynamics and left ventricular function in nephrectomized rats after ischemia-reperfusion injury: a potential direct cardioprotective effect of SGLT2 inhibitor
Event: ESC Congress 2025
Topic: Drugs, Drug Targets
Session: Innovative therapeutic strategies to combat ischaemia-reperfusion injury and cardiac dysfunction
